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ABSTRACT
Introduction. Hip fracture is a major cause of morbidity and mortality 
in older adults. Intertrochanteric hip fractures often are treated surgi-
cally using cephalomedullary nails (CMN), in either a short or long 
length. Their outcomes are documented in the literature; however, out-
comes of the intermediate-length CMN have not been well described.
Methods.xA retrospective review was conducted of older adults with 
intertrochanteric hip fractures that were treated with cephalomed-
ullary nail fixation using an intermediate-length (235 mm Synthes 
Trochanteric Fixation® nail or 240 mm Stryker Gamma 3®) nail. 
Outcome data were collected during the inpatient stay and 16 months 
post-operatively.
 Results. Seventy-seven patients met inclusion criteria and were 
reviewed during inpatient stay; however, only 42 had documented post-
operative outcomes. Of those, two patients died post-discharge and 
were not included in the 16-month follow-up. Comparison of results 
to published literature suggested that intermediate-length nails are 
comparable to short-length nails with regard to time in the operating 
room and estimated blood loss. The rate of blood transfusion was lower 
and length of hospital stay was shorter than in comparable studies of 
both short- and long-length nails. There were no post-operative peri-
prosthetic fractures in the 16-month follow-up. This rate was lower 
than published rates for short and long nails. The hardware failure rate 
(3/42, 7.1%) of intermediate-length nails was higher than comparison 
studies of both short- and long-length nails.  
Conclusion. Patient outcomes for intermediate-length nails were 
similar to outcomes of shorter length nails. Utilization of the interme-
diate-length nail appears to be an effective treatment option for repair 
of intertrochanteric femur fractures. However, direct comparison is 
difficult since peri-prosthetic fracture rate may increase over time and 
nail length and hardware failure are not defined consistently in the lit-
erature.  Further study is needed with a larger sample size followed over 
a longer period of time to confirm our findings. 
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INTRODUCTION
Hip fractures are recognized as a cause of significant morbidity and 
mortality in older adults.1-6 Due to the increasing older adult popula-
tion in the United States,7 the incidence of hip fracture is expected 
to double by the year 2050.8  Over the average lifespan of 80 years, 
approximately 10% of women and 6% of men in the U.S. will experi-
ence a hip fracture, with incidence increasing to 30% of women and 
20% of men sustaining hip fractures by the age of 90.9 About 300,000 
older adults are hospitalized with hip fractures in the U.S. each year, 
half of which are intertrochanteric fractures.9,10 Given the epidemio-
logic significance of hip fractures in the older adult population and 
its subsequent impact to the health care system, it is important that 
researchers continue investigating efficient and effective methods of 
hip fracture repair. 
Historically, intertrochanteric (IT) hip fractures were treated pri-
marily with sliding hip screws (SHS), but after the introduction of the 
cephalomedullary nail (CMN) in the 1980s, the CMN quickly became 
the most common method of repair among orthopaedic surgeons 
in the U.S.11-14 When originally brought to market, CMNs possessed 
theoretical improved fracture fixation biomechanics compared to the 
SHS,15 as well as the advantages of percutaneous insertion, which 
include less surgical exposure and blood loss,16-22  as well as earlier 
rehabilitation.21,23 However, the first generation of short-length nail 
implants was associated with a significantly increased risk of peri-
prosthetic femoral shaft fracture as compared to SHS.24-26 As a result, 
a new “long” nail was introduced to decrease stress concentration at 
the proximal femoral diaphysis and provide diaphyseal interference 
fit to the construct.27  
Initial comparative studies of short vs. long CMN implants revealed 
a lower post-operative peri-prosthetic fracture rate in the longer 
length CMN implants compared to the original, short-length nails.17 
However, by the early 2000s, the increased risk of peri-prosthetic 
femoral shaft fractures associated with CMN devices was decreas-
ing10 as new nail modifications were introduced. Nails became smaller 
in diameter, transitioned from stainless steel to titanium, and were 
constructed to mimic more closely the anatomical anterior bow of the 
femur. The size of the distal interlocking screws also was decreased.28 
In addition to improvements in design over the years, multiple 
orthopaedic device companies have introduced CMN devices to 
market. The Depuy Synthes and Stryker companies occupy a sig-
nificant share of the CMN market in the U.S.29 Short nails are a fixed 
length, but long nails vary in length (typically 20 mm increments) 
as required by the patient’s femur length. Each company’s product 
information categorizes nail lengths into either a short or long cat-
egory (Table 1).
Table 1. Description of manufacturer nail length product speci-
fications.
Manufacturer Short Nail Long Nail
Depuy Synthes (Trochanteric 
Fixation Nail – TFN®)30
170 mm
235 mm
300 mm - 460 mm
in 20 mm increments
Stryker (Gamma3®)31 170 mm
180mm
240 – 480 mm
in 20 mm increments
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that Synthes categorizes their 235 mm nail as “short” and Stryker 
categorizes their 240 mm nail as “long”. The selection of nail implant 
length for a specific patient is based on many factors including fracture 
location and stability, surgeon preference, and implant availability at 
the treatment facility or location.32 
A number of research studies comparing surgical and post-
operative outcomes between short- and long-length nails have 
been published, suggesting advantages and disadvantages of each 
type.16,17,20,32-36 Advantages of short nails compared to long nails 
include a less technically demanding procedure, shorter operative 
time, less blood loss, decreased transfusion rates and lower hospital 
costs.16,20,32-34 The advantage of the long nail compared to the short 
nail is a stronger construct with a decreased stress concentration in 
the proximal femoral diaphysis leading to lower risk of peri-prosthet-
ic fracture post-operatively.17,35
A number of published studies have compared surgical and post-
operative outcomes of short and long CMNs. However, many of 
these studies only designate the implant selected as either ‘short’ or 
‘long’ (designated by manufacturer) without specifying the exact nail 
implant length.16,28,33,36 To date, no studies have been found document-
ing outcomes when specifically using the longest length “short” nail 
(Synthes TFN® 235 mm) or the shortest length “long” nail (Stryker 
Gamma 3® 240 mm). For the purpose of this study, “intermediate-
length” was defined as either a 235 or 240 mm nail. 
The purpose of this study was twofold: to describe surgical and 
post-operative outcomes of older adult patients undergoing inter-
trochanteric (IT) fracture repair utilizing an “intermediate-length” 
cephalomedullary nail (CMN); and to compare findings with 
outcomes previously published in the literature for short- and long-
length nails.
METHODS
A retrospective chart review was conducted involving a case 
series of older adult patients who sustained an intertrochanteric hip 
fracture repaired with an intermediate-length (Synthes 235 mm or 
Stryker 240 mm) CMN. All procedures were performed between 
January 1, 2015 and December 31, 2015 by two fellowship trained, 
board certified orthopaedic traumatologists at a single, tertiary care 
hospital in the mid-western United States. All patients were followed 
post-operatively at a single outpatient facility. Institutional review 
board approval was obtained from participating institutions.  
Pertinent information included patient age at time of surgery, 
mechanism of injury, pre-operative hemoglobin, post-operative 
hemoglobin, type and length of nail, operative duration, hospital 
length of stay, discharge destination, and post-operative compli-
cations (wound infection, transfusions, non-union, femoral head 
osteonecrosis, hardware failure, and death). Hardware failure was 
defined as femoral head cutout, blade/screw backout, nail failure, 
and distal screw backout/breakage. Successful fracture healing was 
defined as radiographic verification of fracture union or release of 
patient from follow-up by surgeon. All patients > 90 years old at the 
time of surgery were recorded as age 90 to increase anonymity in this 
limited patient population. The information collected was stratified
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 and compared to published outcomes of short- and long-length CMNs 
in similar patient populations (Stryker Gamma 2/3 or Synthes TFN 
nails28,33,34) to characterize efficacy of intermediate-length CMNs. 
Authors reviewed similarly designed retrospective studies28,33,34 in the 
literature comparing post-operative outcomes of short nails and long 
nails to serve as benchmarks for outcomes in this study. 
Inclusion criteria were: (1) diagnosis of intertrochanteric femur 
fracture treated surgical repair (CPT code 27245; treatment of inter-
trochanteric hip fracture with intramedullary nail), (2) age 65 or 
greater, and (3) fracture fixation with an intermediate-length CMN. 
Exclusion criteria were: (1) subtrochanteric fracture, (2) isolated 
fracture of the greater or lesser trochanter, (3) pathologic fracture, 
(4) no documented follow-up during 16 months post-operative 
period, and (5) revision of previous hip surgery. 
A search of patient databases at the hospital and outpatient clinic 
was conducted identifying 135 potential subjects for further screen-
ing. Fifty-eight patients were excluded because of age less than 65 
years (29 cases), nail length different from that specified (23 cases), 
and different fracture type or location than specified (s cases), leaving 
77 patients for further study. Only inpatient data were available for 
an additional 33 patients who were lost to follow-up during the post-
operative period. Additionally, two patients died in the post-operative 
period before the 16-month follow-up period. Therefore, 42 subjects 
were followed during both the inpatient and outpatient periods.
RESULTS
A total of 77 patients met inclusion criteria (Table 2). Average 
age at the time of surgery was 82.5 years and 31% were over the age 
of 89. Most patients were female (67.5%) and a fall from standing 
height was the mechanism of injury for 76 of 77 patients (98.7%). Of 
these patients, 25 (32.5%) fractures were repaired surgically using a 
Stryker Gamma® 240 mm intermediate-length nail and 52 (67.5%) 
were repaired using a Synthes TFN® 235 mm intermediate-length 
nail. All nails were locked distally.
The patient age, type of nail utilized, and in-patient surgical out-
comes in the current study were compared with three studies in 
the literature, all documented outcomes of short- and long-length 
nails (Table 3). Dunn et al.33 published a systematic review, pooling 
data from four studies (1276 patients). Guo et al.34 conducted a ret-
rospective study of 178 patients at one institution and Kleweno et 
al.28 performed a retrospective study of 559 patients at three trauma 
centers over a six-year period. The mean age of our study cohort 
was comparable to the average age of patients in these comparison 
studies. The mean operation time for placement of an intermediate 
nail in our study was 50 minutes. The mean pre-operative hemo-
globin was 11.8 gm/dl, while the mean post-operative hemoglobin 
was 8.9 gm/dl. Mean estimated blood loss was 94.0 ml. The mean 
post-operative hemoglobin (Day #1; gm/dl) was 8.9 (1.6). Twenty 
(26%) patients required post-operative packed red blood cell trans-
fusion; with a mean of 1.3 units. During the hospital stay, 2 of the 77 
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patients (2.6%) suffered a superficial wound infection. No patients 
suffered deep infection or peri-prosthetic fracture during their hos-
pital stay. Two (2.6%) patients expired during the hospital stay. The 
comparison studies did not report post-operative hemoglobin (Day 
#1), mean transfusion units, superficial wound infection, and in-hos-
pital mortality.
Table 2. Population demographics and clinical characteristics. 
Total N = 77
Mean age, in years 82.5
Frequency (%) of patients age over 89 24 (31)
Fall detail, frequency (%)
   Standing height fall 76 (98.7)
   > Standing height fall 1 (1.3)
Primary diagnosis (ICD), frequency (%)
S72.141A (intertrochanteric fracture, right) 20 (26.0)
   S72.142A (intertrochanteric fracture, left) 57 (74.0)
Type of nail used (%)
   Stryker Gamma 3® (240 mm) 25 (32.5)
   Synthes TFN® (235 mm) 52 (67.5)
Post-operative outcome data were collected up to 16 months 
following surgery (Table 4). Though 77 patients met our inclusion 
criteria, 2 patients died after discharge and 33 were lost to follow-up 
before fracture union was documented. Of the remaining 42 patients, 
1 (2.4%) had fracture nonunion and 3 (7.1%) had hardware failure, 
defined as either blade/screw backout (two patients) or femoral head 
cutout (one patient). There were no occurrences of peri-prosthetic 
fracture, deep infection, or femoral head osteonecrosis during the 
16-month post-operative period.
Table 3. Comparison of patient age and surgical outcomes. 
Comparison Studies
Current Study 
(intermediate)
Dunn33 
(short) Dunn (long)
Guo34 
(short)
Guo 
(long)
Kleweno28 
(short)
Kleweno 
(long)
N = 77 N = 438 N = 838 N = 102 N = 76 N = 219 N = 340
Type of Nail Stryker 
Gamma 3 or 
Synthes TFN
Stryker 
Gamma 3 or 
Synthes TFN
Stryker 
Gamma 2, 3, or 
Synthes TFN
Stryker 
Gamma 3
Stryker 
Gamma 3
Stryker 
Gamma 3 or 
Synthes TFN
Stryker 
Gamma 2, 3, or 
Synthes TFN
Length of Nail (mm) 235 or 240 mm NR 180 320-360 NR
Mean (SD) Mean Mean Mean Mean Mean Mean
Mean Age 82.5 82 79 82.7 78.9 84
OR Time (min) 50 (9.7) 47 66 44 59 51 70
Pre-Op Hemoglobin (gm/dl) 11.8 (1.7) NR 11 10.9 NR
Estimated Blood Loss (ml) 94.0 (45.1) 96.7 135.2 NR 127.8 NR
Patient receiving transfusion 
packed red blood cells 20 (26%) 41% 50% NR 57% NR
Hospital Length of Stay 
(days) 4.4 7 7.3 12.9 12.7
TFN - trochanteric fixation nail
NR - not reported
Comparison to Published Literature. Tables 2 - 4 compare 
outcomes from the current study to similar published studies in the 
literature.28,33,34 Studies were chosen to compare patient population, 
patient age, and type of nail studied.28,33,34 Our study had a smaller 
sample size, but mean patient age was comparable. The current study 
included Synthes TFN and Stryker Gamma 3 nails, which is similar 
to the comparison studies. Dunn33 and Kleweno28 included an earlier 
version of the Gamma nail (Gamma 2) in addition to including the 
Gamma 3 nail. 
Inpatient surgical outcomes are compared in Table 3. Operating 
room time (mean 50 minutes) was most comparable to short-length 
nails in all three comparison studies. The hospital length of stay (LOS) 
in the current study was shorter than both the short and long nails in 
all comparison studies. Estimated blood loss (EBL) was reported by 
Guo et al.34 for long nails only; Dunn et al.33 reported EBL for long and 
short nails. The current study result of 94 ml (mean) is comparable 
to the short nail reported by Dunn et al.33 The percentage of patients 
requiring a blood transfusion in the current study (26%) was lower 
than in the Dunn et al.33 study (41% for short nails, 50% for long nails) 
and in the Guo et al.34 study (57% for long nails).
Regarding post-operative complications (Table 4), there were 
three patients in the current study (7.1%) who had “hardware failure” 
(blade/screw backout or femoral head cutout). This rate was slightly 
higher than the comparison studies at 0% - 3.5%.28,33,34 There were 
no peri-prosthetic fractures following surgery in the current study. 
In the comparison studies, the peri-prosthetic fracture rate for short 
nails ranged from 0.98%34 to 2.7%28 and the rate for long nails ranged 
from 0.95%33 to 1.50%28.
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Table 4. Comparison of post-operative outcomes. 
Comparison Studies
Current Study 
(intermediate)
Dunn33 
(short) Dunn (long)
Guo34 
(short)
Guo 
(long)
Kleweno28 
(short)
Kleweno 
(long)
Type of nail Stryker Gamma 
3 or Synthes 
TFN
Stryker 
Gamma 3 or 
Synthes TFN
Stryker 
Gamma 2, 3, or 
Synthes TFN
Stryker 
Gamma 3
Stryker 
Gamma 3
Stryker 
Gamma 3 or 
Synthes TFN
Stryker 
Gamma 2, 3, or 
Synthes TFN
Length of nail (mm) 235 or 240 mm NR 180 320-360 NR
N=42 N=438 N=838 N=102 N=76 N=219 N=340
Peri-prosthetic fracture 0 (0.0%) 1.60% 0.95% 0.98% 1.31% 2.70% 1.50%
Follow-up period in months 16 mean 18 mean 21 median 30 
Nonunion 1 (2.4) 0.23% 0.60% 0.98% 0% 0% 1.47%
Deep infection 0 (0.0)  NR 0.98% 1.31% NR
Femoral head osteonecrosis, 
% 0 (0.0)  NR  NR NR
Hardware failure (total), % 3 (7.1) NR 0.98% 0% 3.20% 3.50%
Blade/screw backout, % 2 (4.8) NR NR NR
Femoral head cutout, % 1 (2.4) NR NR 2% 3%
*NR - not reported
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DISCUSSION
Our surgical outcome data for intermediate-length nails are 
comparable to published outcome data for short nails in regard to 
operative time and estimated blood loss. Our hospital length of stay 
and transfusion rate was considerably shorter than both short and 
long nails in all comparison studies. The differences in hospital length 
of stay and transfusion rate are not characteristic of the implant, but 
rather more a function of post-operative management. 
In the outpatient follow-up period, three patients (7.1%) had 
“hardware failure” (blade/screw backout or femoral head cutout). 
This rate was slightly higher than comparison studies, however, a 
determination of significance is uncertain due to our small sample 
size.28,33,34 Moreover, direct comparison of “hardware failure” is dif-
ficult as there is inconsistency in the literature as to how “failure” is 
operationally defined. 
Another important post-surgical outcome is peri-prosthetic 
fracture following surgery. In our study, no cases of peri-prosthetic 
fracture were noted in the 16-month follow-up period. In compari-
son studies, the peri-prosthetic fracture rate for all nail lengths was 
higher, ranging from 0.95% to 2.70%. There is some evidence, 
however, that peri-prosthetic fractures may increase over time.37 
Lindvall et al.37 published a retrospective cohort study of 609 patients 
followed over a five-year period after fracture repair with short and 
long nails. They noted that fractures steadily increased during the 
period reaching nearly 10% in five years. Additional follow-up time 
would be required to compare incidence of peri-prosthetic fracture 
rates for the intermediate-length nail. Finally, one patient (2.4%) had 
fracture nonunion. On a percentage basis, our rate of nonunion was 
higher than in comparison studies. However, direct comparison of 
complication rates is problematic due to our small sample size. 
While costs associated with use of the different length nails were 
not considered in this study, it would be an important area for future 
study and consideration. Complication rates have dropped signifi-
cantly to a statistically comparable rate for both short and long nails,28 
and review of recent literature28,34,38,39 suggested that there is little 
advantage using one nail length over the other for stable, intertrochan-
teric fractures. It will be important to consider the cost-effectiveness 
of using longer length nails when taking into consideration the higher 
cost of hospitalization (longer OR time, higher EBL and transfusion 
rates) associated with use of the longer nail.32,33 
Study Limitations. This study was limited by small sample size 
and relatively short (16 month) length of follow-up time compared 
to other studies. It is possible that occult non-unions may have been 
present, however, post-operative outcome data were collected as 
documented in the patient record. A longer follow-up period will 
be necessary to compare complication rates accurately. The study 
was also limited to two treating surgeons in one facility in the mid-
western United States. Comparison of our outcomes to previously 
published literature was limited by failure of these studies to define 
basic parameters such as length of the nails implanted and the 
meaning of terms such as “hardware failure” in those studies.
Statistical comparison to published studies was not achievable, but 
it was possible to compare the outcomes to evaluate performance. 
In our study, outcomes of the intermediate-length nail were most 
comparable to outcomes of the short-length nail in other studies with 
respect to OR time and EBL. Rates of nonunion and hardware failure 
were slightly higher in our small population. Our peri-prosthetic 
fracture rate was lower than in comparison studies. However, our 
follow-up period was limited to 16 months.
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CONCLUSION
This case series was an important first step in describing surgi-
cal and post-operative patient outcomes of the intermediate-length 
nail. Results of this case series suggested post-operative out-
comes for intermediate-length nails are similar to outcomes of the 
shorter-length nails. Comparisons of outcomes indicated that the 
intermediate-length nail is an effective treatment option for surgical 
repair of intertrochanteric femur fractures. Further study is needed 
with a larger sample size and longer follow-up period to determine 
statistical significance. With increasing emphasis being placed on 
economy in healthcare, it is important to identify methods of hip frac-
ture repair that are not only efficient and effective, but also financially 
prudent. Therefore, further research also should be conducted taking 
the cost of each nail into account to determine which length provides 
the best outcomes and the smallest financial burden.
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